Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.
about
T Cell Epitope Peptide Therapy for Allergic DiseasesImmunoregulatory T cell epitope peptides: the new frontier in allergy therapyFold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergenTolerance induction in memory CD4 T cells requires two rounds of antigen-specific activation.Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccinationAllergen immunotherapy: current and new therapeutic strategies.Synthesized OVA323-339MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cellsProphylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy.Inhibition of human T-cell responses by allergen peptides.Type 2 immune-inducing helminth vaccination maintains protective efficacy in the setting of repeated parasite exposures.Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology.Peptide-based immunotherapy: a novel strategy for allergic disease.Animal models of allergen-induced tolerance in asthma: are T-regulatory-1 cells (Tr-1) the solution for T-helper-2 cells (Th-2) in asthma?The efficiency of peptide immunotherapy for respiratory allergy.Evaluation of therapeutic sublingual vaccines in a murine model of chronic house dust mite allergic airway inflammation.Immunotherapy with allergen peptides.Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.Immune response modulation by recombinant peptides expressed in virus-like particles.Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy.Intranasal treatment with ovalbumin but not the major T cell epitope ovalbumin 323-339 generates interleukin-10 secreting T cells and results in the induction of allergen systemic tolerance.
P2860
Q26771989-BB7B3EFC-C49B-4A0E-8B44-6DD6B945DF16Q26822702-119F4B3F-4F0C-447F-AD6D-009732601686Q28833624-41D72024-37CA-4C55-932F-6F6F65CBFFF1Q33694715-7C892BB9-C315-4E10-B856-50AE6F15ECFEQ33883053-029ECE79-79B4-4D2C-8A75-934A9B51B5B8Q34074753-68276EC3-4D05-4B4F-934B-994AA16B0B77Q34329409-4A7318DF-2B8F-47CD-A1C4-603FF8BD2EA3Q34430399-AB4C8F25-9135-4796-B027-1DFBD64A95F5Q34567734-620862EA-6AFC-4B68-B015-D753B7CB5650Q35111535-8D2164A2-6508-4302-9AF5-EB7270B582AEQ36337335-C75A6CAD-BD9C-4855-A710-8388A43CF4BAQ36350581-849146F1-FF6A-428F-BC5B-6D2342EC5D9BQ36360525-00505A2B-5E2F-4719-B456-B32968E4A4B4Q38744223-C386DFE1-DDE3-4C42-8161-7E575E6F470FQ39686005-08EA249E-4F7A-4FB4-A5D1-3FE7788F521FQ40657944-67067E5F-81E9-4A1F-ADA2-9E9A3AAA2664Q45102968-33336C9A-4B70-4FC0-AA38-9F0148EE4087Q45733509-ADB600D4-F471-4BC0-BB66-36D6DBF65A37Q47346696-4A8BD25B-AB1F-4554-B93D-11C4005ABCEAQ47776275-EE901EBC-8272-41B6-B653-63F3585E58F7
P2860
Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Modulation of the allergic imm ...... birch pollen allergen Bet v 1.
@en
type
label
Modulation of the allergic imm ...... birch pollen allergen Bet v 1.
@en
prefLabel
Modulation of the allergic imm ...... birch pollen allergen Bet v 1.
@en
P2093
P1476
Modulation of the allergic imm ...... birch pollen allergen Bet v 1
@en
P2093
P304
P356
10.1046/J.1365-2249.1997.D01-953.X
P577
1997-03-01T00:00:00Z